Trump, Fauci disagree on effectiveness of hydroxychloroquine
More COVID-19 patients receive anti-malaria drug despite controversy.
Read more
 
How health execs, employees are responding to COVID-19
From our sister publication, Managed Healthcare Executive®: Six healthcare executives reveal how they and their organizations have responded to the outbreak.
Read more
 
EDITOR'S PICK
Drugmaker halts access to COVID drug as FDA approves novel test
First point-of-care test to detect coronavirus is cleared, even as one pharma maker is forced to halt access to an experimental medication due to overwhelming demand.
Read more